Ovid Therapeutics Inc. · NASDAQ:OVID

Eventide Asset Management, LLC reported a 7.30% stake in Ovid Therapeutics Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Eventide Asset Management, LLC reported a 7.30% stake in Ovid Therapeutics Inc., 12,773,577 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
7.30%
Shares
12,773,577
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Eventide Asset Management, LLC7.30%12,773,577
Finny Kuruvilla, M.D., Ph. D.7.30%12,773,577
Robin C. John7.30%12,773,577

Source

View original at SEC

Related